Singapore markets closed

Vicarious Surgical Inc. (RBOT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
0.3104+0.0090 (+2.99%)
At close: 04:00PM EDT
0.3104 0.00 (0.00%)
After hours: 06:12PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 45.70M
Enterprise value -23.84M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.54
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.40

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3-85.73%
S&P500 52-week change 322.38%
52-week high 32.4550
52-week low 30.2000
50-day moving average 30.3242
200-day moving average 30.5527

Share statistics

Avg vol (3-month) 3594.14k
Avg vol (10-day) 3389.53k
Shares outstanding 5127.6M
Implied shares outstanding 6147.22M
Float 872.34M
% held by insiders 138.64%
% held by institutions 152.31%
Shares short (15 Apr 2024) 46.17M
Short ratio (15 Apr 2024) 410.31
Short % of float (15 Apr 2024) 45.79%
Short % of shares outstanding (15 Apr 2024) 43.51%
Shares short (prior month 15 Mar 2024) 45.77M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-40.71%
Return on equity (ttm)-71.21%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -71.8M
Net income avi to common (ttm)-61.15M
Diluted EPS (ttm)-0.3800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)84.13M
Total cash per share (mrq)0.57
Total debt (mrq)14.59M
Total debt/equity (mrq)17.37%
Current ratio (mrq)17.16
Book value per share (mrq)0.48

Cash flow statement

Operating cash flow (ttm)-58.19M
Levered free cash flow (ttm)-33.33M